CERo Therapeutics (CEROW) Competitors $0.01 0.00 (0.00%) (As of 12/17/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrends CEROW vs. ATNFW, SXTPW, DRTSW, WENAW, APLMW, BCTXW, CDIOW, CTCXW, CELUW, and CINGWShould you be buying CERo Therapeutics stock or one of its competitors? The main competitors of CERo Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Anew Medical (WENAW), Apollomics (APLMW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Celularity (CELUW), and Cingulate (CINGW). These companies are all part of the "biotechnology" industry. CERo Therapeutics vs. 180 Life Sciences 60 Degrees Pharmaceuticals Alpha Tau Medical Anew Medical Apollomics BriaCell Therapeutics Cardio Diagnostics Carmell Celularity Cingulate 180 Life Sciences (NASDAQ:ATNFW) and CERo Therapeutics (NASDAQ:CEROW) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their valuation, institutional ownership, risk, dividends, earnings, profitability, media sentiment, community ranking and analyst recommendations. Does the media favor ATNFW or CEROW? In the previous week, CERo Therapeutics had 1 more articles in the media than 180 Life Sciences. MarketBeat recorded 1 mentions for CERo Therapeutics and 0 mentions for 180 Life Sciences. 180 Life Sciences' average media sentiment score of 1.87 beat CERo Therapeutics' score of 0.44 indicating that 180 Life Sciences is being referred to more favorably in the media. Company Overall Sentiment 180 Life Sciences Very Positive CERo Therapeutics Neutral Which has preferable valuation and earnings, ATNFW or CEROW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/ACERo TherapeuticsN/AN/AN/AN/AN/A Is ATNFW or CEROW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A CERo Therapeutics N/A N/A N/A Does the MarketBeat Community prefer ATNFW or CEROW? 180 Life Sciences and CERo Therapeutics both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperform180 Life SciencesN/AN/ACERo TherapeuticsN/AN/A Summary180 Life Sciences and CERo Therapeutics tied by winning 1 of the 2 factors compared between the two stocks. Ad Brownstone ResearchDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but designed to power a $9 trillion AI revolution. And I’ve identified a little-known supplier Elon is depending on to make it all happen.I urge you to watch this video now. Get CERo Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for CEROW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CEROW vs. The Competition Export to ExcelMetricCERo TherapeuticsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$203.09M$5.14B$9.31BDividend YieldN/A3.54%4.81%4.06%P/E RatioN/A317.19135.1917.53Price / SalesN/A16,054.991,232.15140.37Price / CashN/A11.7840.6537.95Price / BookN/A7.284.884.92Net IncomeN/A-$18.42M$118.97M$225.78M7 Day PerformanceN/A186.24%15.41%-1.58%1 Month PerformanceN/A133.36%15.47%6.67%1 Year PerformanceN/A112.74%34.58%22.48% CERo Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CEROWCERo TherapeuticsN/A$0.01flatN/AN/A$0.00N/A0.008Gap UpATNFW180 Life SciencesN/A$0.01-16.5%N/A+41.0%$0.00N/A0.007Positive NewsGap DownSXTPW60 Degrees PharmaceuticalsN/A$0.01flatN/AN/A$0.00$502,409.000.002Gap UpDRTSWAlpha Tau MedicalN/A$0.25+8.8%N/A+4.1%$0.00N/A0.0080News CoverageGap UpWENAWAnew MedicalN/A$0.04-0.3%N/AN/A$0.00N/A0.00N/AGap DownAPLMWApollomicsN/A$0.01-6.0%N/A-72.3%$0.00N/A0.0059BCTXWBriaCell TherapeuticsN/A$0.50+14.4%N/A-80.9%$0.00N/A0.008High Trading VolumeCDIOWCardio DiagnosticsN/A$0.05-6.0%N/A-48.0%$0.00$35,688.000.007Gap DownHigh Trading VolumeCTCXWCarmellN/A$0.04+4.9%N/AN/A$0.00$32,839.000.009Gap UpCELUWCelularityN/A$0.02+5.8%N/A+196.3%$0.00$42.69M0.00220Gap UpCINGWCingulateN/A$0.04+15.2%N/A+56.0%$0.00N/A0.0013 Related Companies and Tools Related Companies ATNFW Competitors SXTPW Competitors DRTSW Competitors WENAW Competitors APLMW Competitors BCTXW Competitors CDIOW Competitors CTCXW Competitors CELUW Competitors CINGW Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CEROW) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersTrump’s Secret Manhattan ProjectOn January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredHow this >10-cent coin is going to outperform Bitcoin Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CERo Therapeutics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CERo Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CEROW Stock Alerts